title: Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel.
authors.affiliation: Université Côte d'Azur, CNRS, Inserm, iBV, Nice, Marseille, France.
authors.forename: Raphael
authors.initials: R
authors.lastname: Rapetti-Mauss
authors.affiliation: Université Côte d'Azur, CNRS, Inserm, iBV, Nice, Marseille, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Soriani
authors.affiliation: Service d'Hématologie, Hôpital L'Archet, Nice, Marseille, France.
authors.forename: Henri
authors.initials: H
authors.lastname: Vinti
authors.affiliation: UMR_S Inserm 910, Aix-Marseille Université, APHM Département de Génétique Médicale, Hôpital de la Timone, Centre de Référence Thalassémie, Marseille, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Badens
authors.affiliation: Université Côte d'Azur, CNRS, Inserm, iBV, Nice, Marseille, France guizouar@unice.fr.
authors.forename: Hélène
authors.initials: H
authors.lastname: Guizouarn
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000745:Anemia, Hemolytic, Congenital / Q000188:drug therapy*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D015160:Hydrops Fetalis / Q000188:drug therapy*; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels / Q000235:genetics*; D009154:Mutation; D011188:Potassium / Q000378:metabolism; D014162:Transfection; D014320:Triphenylmethyl Compounds / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels; C496923:KCNN4 protein, human; D014320:Triphenylmethyl Compounds; D011188:Potassium; C472774:senicapoc